Summary
Biomarkers are measurable biological indicators that reflect the state of your health at a cellular and systemic level, and they are the foundation of biology-first longevity research. This guide covers five key categories: hormonal health, inflammation, metabolic health, organ function, and cellular and longevity markers. The Pepvela philosophy is to know your biology first, which means establishing a clear baseline before engaging with any research protocol. Biomarkers also provide essential context for peptide research, because many peptides have proposed mechanisms that interact with pathways these markers measure. Throughout, working with a licensed healthcare provider for testing and interpretation is strongly recommended.
Why Biomarkers Matter in Longevity Research
At a biological level, biomarkers measure the concentration or activity of specific molecules and cells, from hormones and inflammatory proteins to glucose, enzymes, and indicators of organ function. Taken together, they offer a snapshot of how the body's systems are operating, which is far more informative than how a person feels on any given day.
Baseline data is essential because you cannot track change without a starting point. Research suggests that interpreting any intervention, including a longevity or peptide research protocol, depends on knowing where the relevant markers stood beforehand. Without that baseline, it is difficult to distinguish a real shift from normal day-to-day variation.
Biomarker tracking has become central to modern longevity research and precision medicine, where the goal is to tailor decisions to an individual's measurable biology rather than population averages. This is the core Pepvela principle: know your biology first. The numbers come before the protocol, not the other way around.
The Five Key Biomarker Categories
Longevity researchers tend to group biomarkers into a handful of functional categories. The five below provide a practical map for understanding what the body's major systems are doing.
Hormonal Health Biomarkers
Hormonal biomarkers reveal how the endocrine system, which governs growth, metabolism, reproduction, and stress, is functioning. Commonly tracked markers include testosterone (total and free), IGF-1, DHEA-S, the thyroid panel including TSH along with T3 and T4, estradiol, and LH and FSH. Research suggests hormonal balance is central to longevity research because these signals influence body composition, energy, recovery, and cellular maintenance. Hormonal markers are also frequently referenced alongside growth hormone and longevity peptide research.
Inflammation Markers
Chronic low-grade inflammation is a major focus of longevity research, sometimes described in the literature as inflammaging. Commonly tracked markers include hs-CRP and homocysteine, along with ESR, fibrinogen, and IL-6, which do not yet have dedicated Pepvela profiles. Research suggests persistent inflammation is associated with many age-related processes. Several peptides, including BPC-157, TB-500, and KPV, have been studied for anti-inflammatory effects in preclinical models, which is why inflammation markers often appear in that research context.
Metabolic Health Biomarkers
Metabolic biomarkers reveal how the body manages cellular energy and glucose regulation. Commonly tracked markers include fasting glucose, HbA1c, fasting insulin, the derived HOMA-IR estimate of insulin resistance, and a lipid panel covering LDL, HDL, triglycerides, and ApoB. Research suggests metabolic health is closely tied to healthspan. This category connects directly to GLP-1 and metabolic peptide research, where glucose and insulin markers provide important context.
Organ Function Biomarkers
Organ function markers matter in any research protocol because they reflect how the liver, kidneys, and blood-forming systems are handling day-to-day demands. Commonly tracked markers include liver enzymes (ALT, AST, GGT), kidney function (creatinine, BUN, eGFR), and a complete blood count (CBC). These do not yet have dedicated Pepvela biomarker profiles. Research suggests baseline organ function data is considered essential context before any protocol, because it establishes a safety reference point against which later changes can be compared.
Cellular and Longevity Biomarkers
A newer set of biomarkers aims to measure aging more directly at the cellular level. Emerging markers include telomere length, NAD+ levels, methylation-based biological age tests, CoQ10, and Vitamin D. Most of these do not yet have dedicated Pepvela profiles. Research suggests these markers are gaining attention in longevity and healthspan research because they attempt to capture biological age rather than chronological age. They remain an active and evolving area of study.
How to Build Your Baseline Biomarker Panel
A baseline panel is a set of biomarkers measured before starting anything new, so that future results can be compared against a known starting point. It matters because it turns vague impressions into data, and it is the step the Pepvela philosophy treats as non-negotiable.
As a starting framework, longevity researchers commonly track a core baseline that includes a CBC, a comprehensive metabolic panel (CMP), a lipid panel, fasting glucose, HbA1c, TSH, testosterone, IGF-1, hs-CRP, homocysteine, and Vitamin D. This is not medical advice or a prescription; it is a description of what is frequently tracked in a research context. The right panel for any individual depends on their goals and health history.
The practical step is to work with a licensed healthcare provider or a functional medicine doctor to order and interpret appropriate tests. Pepvela plans to add lab testing resources and partner options, such as Marek Health, Ulta Lab Tests, and Function Health, as future resources to help researchers access testing. The Pepvela Lab Testing Guide covers how to approach lab testing in a research context. Read the Lab Testing Guide.
How Biomarkers Connect to Peptide Research
Many peptides studied in longevity research interact with pathways that biomarkers can measure, which is why the two are often examined together. The table below maps each biomarker category to commonly tracked markers and the peptide research areas they relate to.
| Biomarker Category | Commonly Tracked Markers | Related Peptide Research Areas |
|---|---|---|
| Hormonal | IGF-1, Testosterone, DHEA-S | Growth hormone peptides, longevity peptides |
| Inflammation | hs-CRP, ESR, Homocysteine | BPC-157, TB-500, KPV, immune peptides |
| Metabolic | Fasting Glucose, HbA1c, Insulin | GLP-1 peptides, metabolic compounds |
| Organ Function | ALT, AST, Creatinine, CBC | Baseline monitoring for any protocol |
| Cellular | NAD+, Vitamin D, CoQ10 | Longevity peptides, mitochondrial research |
Explore the full Pepvela Peptide Library to see how individual peptides connect to specific biomarker categories.
The Pepvela Approach: Know Your Biology First
The core Pepvela philosophy is simple to state and demanding to follow: know your biology first. Testing before any protocol is the foundation of responsible longevity research, because data turns a guess into an informed decision. Baseline biomarkers tell you where you are starting, give your healthcare provider real context, and make it possible to see whether anything actually changed.
The Pepvela ecosystem is built to connect these pieces, linking biomarkers to the peptide research that relates to them and, in turn, to the process of building a thoughtful protocol. The longer-term vision is a personalized longevity intelligence platform grounded in your own data, where understanding always comes before action. The order of operations is the point: biology first, research second, decisions last.
Continue Your Research
Biomarker Library
Browse detailed research profiles for key longevity and health biomarkers.
Lab Testing Guide
Understand how to approach lab testing in a research context.
Peptide Library
Explore how peptides connect to specific biomarker categories and research goals.
Peptide Finder
Find peptides relevant to your research goals and biology.
References
- Lopez-Otin C et al. -- "The Hallmarks of Aging" -- Cell -- 2013
- Barzilai N et al. -- "The Critical Role of Metabolic Pathways in Aging" -- Diabetes -- 2012
- Levine ME et al. -- "An epigenetic biomarker of aging for lifespan and healthspan" -- Aging -- 2018
- Franceschi C et al. -- "Inflammaging: a new immune-metabolic viewpoint for age-related diseases" -- Nature Reviews Endocrinology -- 2018
- Pepvela Biomarker Library -- pepvela.com/biomarkers-library